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Development and differentiation of endothelium. Vascular endo-
thelial cells play an important role in tissue homeostasis, fibrino-
lysis, and coagulation; blood-tissue exchange, vasotonus regula-
tion, blood cell activation, and migration; and the vascularization
of tissues. The formation of new blood vessels comprises two
distinct steps: vasculogenesis, the in situ assembly of capillaries,
and angiogenesis, the sprouting of capillaries from preexisting
ones. Vascular endothelial growth factor (VEGF) is essential for
vasculogenesis and angiogenesis. Its expression is high in the
embryonic brain and kidney when angiogenesis occurs and low in
the adult brain when angiogenesis is absent. In the kidney, VEGF
expression remains high in glomerular podocytes even in the
adult. VEGF receptors 1 and 2 (fit-1 and flk-1) are endothelial-
specific receptor tyrosine kinases. Similar to the ligand, expression
of these receptors is high during brain and kidney angiogenesis,
low in adult brain endothelium, but high in adult glomerular
endothelium. Because VEGF is also a vascular permeability
factor, the expression in the adult correlates with the low perme-
ability of blood-brain barrier endothelium and the high perme-
ability of fenestrated glomerular endothelium. Although fenestrae
formation can be induced in vitro by VEGF and a basal lamina-
type extracellular matrix, blood-brain barrier characteristics seem
to require the presence of still unknown brain-derived factors.
DEVELOPMENT OF ENDOTHELIAL CELLS
In the embryo, the cardiovascular system is the first
organ system to develop. Angioblasts differentiate from the
mesoderm and subsequently form a primitive vascular
plexus. This process is called vasculogenesis, as reviewed in
[1]. The subsequent process of sprouting of new capillaries
from the preexisting network is called angiogenesis. Angio-
blasts also differentiate from the mesodermal precursors
within organ rudiments of the lung, pancreas, and spleen
[2]. Notably, all of these organs are of endodermal origin,
whereas organs of ectodermal or mesenchymal origin seem
to be vascularized, at least partly, by an angiogenic mech-
anism, such as kidney and brain [3–5]. The molecular
mechanisms underlying these processes are still only poorly
understood, but progress has been made recently. In an
avian model system, endothelial cell differentiation can be
induced in vitro by incubation of pluripotent embryonic
cells (epiblast cells) with basic fibroblast growth factor
(bFGF) [6]. The first molecule so far known to be ex-
pressed in a population of mesodermal cells giving rise to
angioblasts is the VEGF receptor-2 [VEGFR-2; also
known as flk-1 in the mouse and kinase insert domain
receptor (KDR) in the human]. The crucial importance of
this receptor is underlined by the early lethality resulting
from the absence of hematopoietic and endothelial cells in
mice deficient for this molecule. Later, during embryonic
development, VEGFR-2 becomes restricted to endothelial
cells consistent with the function of its ligand VEGF as a
specific endothelial cell growth and vascular permeability
factor. Mice deficient for a single VEGF allele show
embryonic lethality due to defective large vessel develop-
ment and capillary sprouting. This severe haploid-insuffi-
cient phenotype suggests that critical thresholds of VEGF
protein may be required for activating the VEGF receptors
in early development, as reviewed in [7].
Hypoxia is a rapid and potent inducer of VEGF mRNA
expression. Hypoxia-induced transcriptional activation is
mediated by direct binding of hypoxia-inducible factor-1
(HIF-1), a basic helix-loop-helix (bHLH) Period, Aryl-
hydrocarbon-receptor, single minded (PAS)-domain tran-
scription factor. VEGF up-regulation is also achieved by
increased RNA stability [8, 9]. Hypoxia may play a role in
the regulation of VEGF-dependent developmental angio-
genesis, for example, in the brain and retina. We have
cloned a novel bHLH-PAS-domain protein showing a high
degree of homology to HIF-1. This was termed HIF-related
factor (HRF). HRF mRNA is highly expressed by brain
capillary endothelial cells in the embryo and the adult but
also in other vascular beds such as the kidney glomeruli and
choroid plexus. Expression of HRF is, however, not re-
stricted to the endothelium: smooth muscle cells, epithelia,
and neurons also have detectable amounts of HRF mRNA
[10]. HRF is distinguished from its close relative HIF-1 by
its distinct expression pattern that implies a role for the
factor during tubulogenesis. Tubular networks, which are
propagated by branching and sprouting of terminal cells,
are also known in invertebrates, such as the tracheal system
in insects, the morphogenesis of which closely resembles
that of the vertebrate vascular system [11]. In Drosophila,
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the bHLH-PAS-domain protein trachealess has been iden-
tified as a master regulator of tracheogenesis [12]. Inter-
estingly, the amino acid sequence of the DNA binding basic
domain is identical to that of HIF-1, and HRF is a more
potent inducer of VEGF than HIF-1. Furthermore, tra-
cheae and blood vessels grow in response to hypoxia. Apart
from the endothelium, HRF expression correlates with
VEGF expression in the kidney glomeruli and the choroid
plexus. There, in contrast to VEGF, HRF is highly ex-
pressed not only in the epithelial, but also in the endothelial
cells where VEGF receptors are present at high levels at
this stage of development [13].
ORGAN-SPECIFIC ENDOTHELIUM
On the basis of morphology, microvascular endothelium
in the normal adult organism is divided into different
phenotypes: continuous, fenestrated, and discontinuous.
The morphological differences correlate with vascular per-
meability. In continuous capillaries, the endothelial cyto-
plasm is continuous, and there is no fusion of luminal and
abluminal plasma membranes, except at the cell junctions.
Discontinuous endothelial cells usually have clustered
holes of 80 to 200 nm in diameter at the tapering edges of
the cell. Fenestrated endothelium has similar pores with
diaphragms. All of these different characteristics reflect
potential differentiation pathways of endothelial cells,
which have formed capillaries in a given organ or tissue by
vasculogenesis or angiogenesis, as reviewed in [14]. Inter-
action of both types of endothelium with the organ and
tissue environment, either by soluble factors or via cell-cell
interaction, leads to the particular phenotype of the endo-
thelium. It is unclear whether the differentiation of organ-
specific characteristics in organ-derived endothelium is
already predetermined. In any case, a single organ such as
the kidney contains many different types of endothelial
cells, such as, fenestrated, diaphragmed endothelium in
peritubular capillaries, fenestrated, nondiaphragmed (or
“porous”) endothelium in glomerular capillaries, and con-
tinuous endothelium in other parts. In lymph nodes, “high”
endothelial cells are found specifically in postcapillary
venules. In the brain, circumventricular organs have fenes-
trated endothelium, whereas other brain capillaries form
the blood-brain barrier. Organ-specific differentiation of
endothelial cells is reversible. Fenestrations and blood-
brain barrier properties, for example, are lost from endo-
thelial cells invading different organs and tumors [15]. Also,
endothelial cells lose organ-specific properties when re-
moved from the organ environment and cultured in vitro.
This loss of organ-specific characteristics, such as, fenestra-
tions [16] and the high electrical resistance of the blood-
brain barrier [17], has been observed in many cultured
endothelial cells.
BRAIN ANGIOGENESIS AND BLOOD-BRAIN
BARRIER ENDOTHELIUM
The development of the brain vascular system begins
when angioblasts enter the head region and form the
perineural vascular plexus that covers the entire surface of
the neural tube. The vascular system within the central
nervous system (CNS) does not develop by vasculogenesis
but originates from the perineural plexus when vascular
sprouts invade the proliferating neuroectoderm at day 10 of
embryonic development in rodents. It is maximal in the
early postnatal period and down-regulated in the adult
brain [18]. Experiments using embryonic brain tissue of the
chicken transplanted into ectopic sites of quail embryos
have confirmed that the transplanted brain tissue of the
chicken can induce ingrowth of vascular sprouts and,
therefore, angiogenesis in the quail. Moreover, the grafted
neural tissue induces blood-brain barrier characteristics in
the host-derived endothelial cells [19, 20].
Brain angiogenesis seems to be regulated by angiogenic
factors secreted by the brain. The spatial and temporal
expression pattern of VEGF mRNA corresponds closely
with angiogenesis during embryonic development in the
mouse brain. By in situ hybridization, we have shown that in
day 17 mouse embryos VEGF mRNA is expressed in the
ventricular layer of the developing neuroectoderm [13]. In
adult brain, where vascularization is complete and the rate
of endothelial cell proliferation is very low, VEGF mRNA
is no longer detected in the ependymal cells. It is, therefore,
conceivable that during brain development VEGF is re-
leased by cells of the ventricular layer, thus promoting
angiogenesis by initiating migratory and mitogenic re-
sponses by endothelial cells from the perineural vascular
plexus. These endothelial cells express VEGFR-2 mRNA
during the period of brain vascularization. In the adult
brain, when angiogenesis has ceased, expression is very low.
Taken together, these findings support the hypothesis that
VEGFR-2-expressing capillary sprouts, originating from
the perineural vascular plexus, migrate toward an angio-
genic stimulus provided by VEGF.
Expression of the tie-1 and tie-2 receptor mRNAs is very
similar to that of the high-affinity VEGF receptors, sug-
gesting that they also might be involved in brain angiogen-
esis. However, the phenotype of the tie-1 and tie-2 recep-
tor-deficient mice differs from that of VEGF receptor-
deficient mice [21]. Most strikingly, no sprouting of
capillaries into the brain is seen in tie-2 mutant mice,
although a perineural plexus is formed normally. Ligands
for the tie-2 receptor, called angiopoietins, have been
identified recently and are expressed at sites of vascular
sprouting and remodeling [22, 23]. Thus, brain angiogene-
sis requires at least two different ligand-receptor systems
that are involved in different aspects of the complex process
of vascular sprouting, migration, invasion, and prolifera-
tion.
Risau: Development and differentiation of endotheliumS-4
During late embryonic and early postnatal development
in rodents, brain capillaries become impermeable to pro-
teins and differentiate to blood-brain barrier endothelium.
Tight junctions between brain endothelial cells are the
structural basis for the paracellular impermeability and
high electrical resistance of these endothelial cells. During
brain angiogenesis, the decrease in vessel permeability to
protein correlates with a conformational change of the tight
junctions. We have analyzed quantitatively the structure
and function of tight junctions in primary cultures of bovine
brain endothelial cells using quantitative freeze-fracture
electron microscopy and ion and inulin permeability [24].
We found a complex network of P-face-associated tight
junctions only in the capillaries and postcapillary venules of
the brain cortex. Tight junctions in peripheral, nonbarrier
endothelial cells are E-face-associated in vivo. Consistent
with the development of physiological barrier properties,
that is, electrical resistance and low permeability, P-face-
associated junctional particles form during the develop-
ment of blood-brain barrier capillaries from embryonic day
13 to postnatal day 1 [25]. The molecular mechanisms
involved in the gain and loss of P-face association of tight
junctions are unknown. There is, however, evidence that
tight junctions are associated with the cytoskeleton [26],
which seems to be important for the regulation of paracel-
lular permeability, suggesting that the cytoplasmic anchor-
ing of the tight junctions plays an important role.
FENESTRATED ENDOTHELIA
Fenestrated capillaries are more permeable to low-
molecular weight, hydrophilic molecules than continuous
capillaries, which is consistent with the presence of fenes-
trated endothelium at sites of filtration, secretion, and
absorption [27]. The only molecular difference from all
other endothelial plasma membranes known so far is the
clustering of anionic cell-surface molecules at fenestrations
[28]. Because fenestrated endothelium occurs in close
proximity to epithelium, interaction between the two cell
types has been thought to be important for the differenti-
ation and maintenance of fenestrae. As mentioned earlier
here, epithelial cells adjacent to fenestrated endothelium,
in the glomerulus and choroid plexus, show a high consti-
tutive expression of VEGF. VEGF, by virtue of its perme-
ability-inducing activities, might therefore induce and sta-
bilize the fenestrated capillary phenotype. Recently, direct
in vivo evidence has been provided by the demonstration of
increased microvascular permeability and endothelial fen-
estration after topical application of VEGF/VPF in muscle
or by intradermal injection. This effect was seen in venous
and capillary endothelium that is not normally fenestrated
in these organs [29]. In an in vitro model system, we have
indeed observed fenestrae induction in endothelial cells
cultured on a basal lamina-type extracellular matrix in the
presence of VEGF [30]. This unique activity of VEGF
therefore provides an opportunity to unravel the molecular
mechanisms involved in the differentiation of fenestrated
endothelium.
CONCLUSIONS AND PERSPECTIVES
Blood-brain barrier and glomerular fenestrated endothe-
lial cells are two functionally important examples of organ-
specific endothelial cells. From the data summarized in this
brief review, a concept emerges that suggests that contin-
uous expression of VEGF in epithelial cells, such as,
podocytes, adjacent to endothelial cells, such as, glomerular
endothelium, that express VEGF receptors induces and
maintains a fenestrated phenotype in the endothelium (Fig.
1). HRF is a candidate factor expressed in podocytes and
Fig. 1. Schematic drawing of the interactions between podocytes/astrocytes and endothelial cells (Endo) in the kidney glomerular and blood-brain
barrier capillaries. Abbreviations are: BL, basal lamina; TJ, tight junctions.
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endothelial cells that may be responsible for the high level
of continuous VEGF and VEGF receptor expression. In
the brain, VEGF and its receptors are down-regulated after
brain angiogenesis has ceased (Fig. 1). This may be because
of the absence of hypoxia in a fully differentiated, highly
vascularized CNS. Although not expressed in brain paren-
chymal cells, HRF mRNA is still expressed by brain
capillary endothelial cells in the adult. The functional
consequence of this expression and the target genes are
unknown. In any case, in addition to the down-regulation of
VEGF in the brain, signals from the brain are needed to
induce the particular blood-brain barrier properties in
endothelial cells, such as P-face-associated tight junctions.
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